logo-en
  • Home
  • Companies
  • Investors
    • Home
  • FinTech Hub
  • News
LoginRegister
  • english iconEnglish
  • english iconArabic
  1. Mubasher News
  2. NUPCO pacts with Sanofi to localize insulin production in Kingdom

NUPCO pacts with Sanofi to localize insulin production in Kingdom

NOHA.GAD
Oct 22, 2024
NUPCO signed an offtake agreement with Sudair Pharma Company and Sanofi to localize insulin production in Saudi Arabia

Riyadh - Sharikat Mubasher: The Saudi National Unified Procurement Company (NUPCO) signed an offtake agreement with Sudair Pharma Company (SPC) and Sanofi, the global healthcare company, to localize the production of key insulin types in Saudi Arabia.

The agreement was signed during the Global Health Exhibition in the presence of the Minister of Health Fahad Al-Jalajel, the Minister of Industry and Mineral Resources Bandar Alkhorayef, the Minister of Investment Khalid Al Falih, and senior officials from the companies, a recent statement revealed.

Under this agreement, SPC and Sanofi will establish a state-of-the-art manufacturing facility in the Kingdom to produce Sanofi’s SoloStar insulin pens and advanced insulin products. The facility will also provide delivery, device assembly, and packaging services.

Sanofi will transfer its technical expertise and global knowledge in biological technologies to SPC for full production in Saudi Arabia.

This partnership aims to reduce the burden of importing medicines, raise local content toward the localization of essential biopharmaceutical industries, and enhance economic diversification.

Fahad Al Shebel, CEO of NUPCO, said: “Through our partnerships with Sanofi and Novo Nordisk, NUPCO is taking a pivotal step in supporting Saudi Arabia’s Vision 2030. By localizing the production of key insulin types, we are not only ensuring a reliable supply of critical medications but also advancing the Kingdom’s goal of building a resilient, self-sufficient healthcare system.”

Meanwhile, Niven Al-Khoury, General Manager of General Medicines for Saudi Arabia and Gulf Countries at Sanofi, commented: “We are proud to sign a pivotal agreement with NUPCO to transfer technology and knowledge and localize insulin production in partnership with Sudair Pharmaceuticals.”

On his part, Yasser Alobaidaa, CEO of SPC, said: “This collaboration is a significant move towards enhancing the Kingdom's pharmaceutical manufacturing capabilities and achieving self-sufficiency in vital medicines. This agreement not only reduces reliance on importing medicines but also serves as a cornerstone for strengthening national drug security.”

It is worth mentioning that NUPCO signed another offtake agreement with Nova Nordisk during the exhibition to localize the manufacturing of three types of insulin in Saudi Arabia.

The Global Health Exhibition 2024 takes place in Riyadh from 21 to 23 October, with the participation of over 1,200 exhibiting brands from more than 40 countries.

Tags

Saudi Arabia
Pharmaceuticals
Healthcare
Global Health Exhibition
Share

Attract clients with your ad

Start Now

Trending

Klivvr upgrades AI financial assistant with In-Chat money transfers
MUBASHER
du unveils National HyperAI to scale AI adoption across UAE
MUBASHER
Monsha’at signed several agreements to strengthen Saudi entrepreneurship ecosystem
MUBASHER.SA
Sabika raises funding to scale precious metals investment platform
MUBASHER
UAE-based fintech firm Mal opens new office in Egypt
MUBASHER

Related News

Private Equities News
Calendar Icon
Nov 16, 2026
du unveils National HyperAI to scale AI adoption across UAE
Read More
Private Equities News
Calendar Icon
Nov 16, 2026
Monsha’at signed several agreements to strengthen Saudi entrepreneurship ecosystem
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
UAE-based fintech firm Mal opens new office in Egypt
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
Alwaleed Philanthropies, RDIA sign strategic R&D partnership
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
HUMAIN partners with VUZ to advance AI Learning through HUMAIN+
Read More
Private Equities News
Calendar Icon
Nov 15, 2026
THC signs $568mn Bombardier deal to launch business aviation fleet
Read More
Private Equities News
Calendar Icon
Nov 12, 2026
FII Institute reschedules 10th Future Investment Initiative to October 2027
Read More

Sharikat Mubasher Newsletter

Get insights and exclusive content from the world of business and finance that you can trust delivered to your inbox

Email is Required
Should be a valid email

Democratizing private equity investments

  • Home
  • Companies
  • Investors
  • FinTech Hub
  • News
  • Contact Us
  • Sitemap
2024 All rights reserved to Sharikat Mubasher